Learn how to develop a transcatheter mitral valve program through the adoption of the MitraClip technology.
Read this brief to get an overview of mitral regurgitation—the primary disease MitraClip aims to treat—and current treatment dynamics.
What you'll learn
Get guidance for deciding whether your organization should develop a transcatheter mitral valve program by adopting MitraClip technology.
The briefing starts with an overview of mitral regurgitation—the primary disease MitraClip aims to treat—and current treatment dynamics. We then dive into the MitraClip technology, outlining the key clinical, financial, and market considerations for adopting the procedure. Lastly, the briefing shares practices for transcatheter mitral valve program development, drawing on the experience of four nationally recognized programs from across the country and recommendations from the major cardiovascular (CV) societies.
Next, Check Out
CRT 2014: What role will MitraClip play in valve programs?